• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Sunday, November 22, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Transcriptomic Meta-Analysis Reveals Divergent Cryptic Splicing in Cortex and Spinal Cord

by
November 21, 2026
in Health
Reading Time: 5 mins read
0
Transcriptomic Meta-Analysis Reveals Divergent Cryptic Splicing in Cortex and Spinal Cord

Transcriptomic Meta-Analysis Reveals Divergent Cryptic Splicing in Cortex and Spinal Cord

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A comprehensive transcriptomic meta-analysis encompassing nearly eighteen hundred RNA sequencing profiles across post-mortem human nervous tissue and cellular models has demonstrated that cryptic splicing events in amyotrophic lateral sclerosis and frontotemporal lobar degeneration diverge markedly between the spinal cord and cerebral cortex. The investigation identified one hundred forty-two cryptic splice variants across sixteen analytical contexts, uncovering sixty-eight novel aberrant splicing events that had evaded detection in previous sequencing screens. Rather than reflecting a uniform consequence of nuclear protein clearance across the central nervous system, aberrant splicing patterns segregated into distinct regional and model-dependent signatures. By evaluating RNA sequencing data from post-mortem donors and experimental systems alongside targeted molecular assays, the research demonstrated that cryptic exon inclusion reflects both canonical TAR DNA-binding protein 43 dysfunction and tissue-specific processes occurring independently of direct protein pathology.

The pathological hallmark of amyotrophic lateral sclerosis and frontotemporal lobar degeneration involves the nuclear depletion and abnormal cytoplasmic aggregation of TAR DNA-binding protein 43, widely designated TDP43. Although previous experimental investigations uncovered high-profile cryptic splicing events in genes such as STMN2 and UNC13A, most prior discoveries relied almost exclusively on in vitro cellular knockdown models or limited cortical sequencing datasets, leaving cryptic splicing profiles across human spinal cord tissue substantially uncharacterized.

To establish an expansive catalog of aberrant splicing, researchers retrieved public bulk RNA sequencing datasets comprising one thousand eight hundred seventy-one post-mortem tissue samples and cell cultures from major repositories including the Gene Expression Omnibus, Sequence Read Archive, and European Genome-Phenome Archive. Following quality control filtering that excluded files failing sequence quality standards, one thousand seven hundred seventy-eight high-quality transcriptomic profiles remained across fourteen distinct central nervous system regions and cell lines. These data incorporated donor cohorts assembled by the New York Genome Center ALS Consortium and the RiMOD-FTD consortium, spanning cerebellar, hippocampal, motor, frontal, temporal, and spinal cord tissues. In addition, the analytical framework incorporated sorted TDP43-negative and TDP43-positive neuronal nuclei derived from frontal cortex, alongside multiple small interfering RNA knockdown experiments. Raw sequencing reads were systematically aligned to the human reference genome GRCh38 using GSNAP, after which splice graph generation and differential splicing testing were conducted using the SGSeq and DEXseq packages.

The bioinformatics discovery pipeline quantified alternative splicing by constructing gene-specific splice graphs composed of non-overlapping exonic nodes connected by splice junction edges, assessing individual path usage as variant frequencies between zero and one. Events were required to meet strict statistical thresholds, specifically an absolute difference in variant frequency exceeding 0.025 at a Benjamini-Hochberg false discovery rate below five percent. Crucially, variants were categorized as authentic cryptic splices only if their control variant frequency was five percent or lower, ensuring that identified junctions represented truly abnormal events. Consolidating significant events across all contexts yielded a catalog of one hundred forty-two cryptic splices, including one hundred thirty-three harboring unannotated junctions.

Unsupervised hierarchical clustering of the one hundred forty-two cryptic splices resolved six distinct modules reflecting tissue, disease, and experimental model specificities across surveyed transcriptomes. Inclusion of the STMN2 cryptic cassette exon 2a stood apart as a universal cross-context event, demonstrating elevation across amyotrophic lateral sclerosis spinal cord, cortical regions, sorted TDP43-negative nuclei, and in vitro knockdown cells. Beyond this shared marker, the analysis delineated a spinal cord-enriched signature of seven cryptic variants that remained virtually undetected in cortical structures or cell models. Cortical tissue exhibited two separate modules, termed Cortical1 and Cortical2, comprising twenty-four and thirty-nine splice variants, respectively. The Cortical1 module encompassed prominent events including the novel terminal cryptic exon in HS6ST3 and the known UNC13A cassette exon. Conversely, an in vitro signature of twenty-seven variants appeared predominantly within neuroblastoma lines but was absent in post-mortem tissues, while a neuronal module of thirty-eight variants characterized depleted cellular models and sorted patient nuclei.

Detailed interrogation of the spinal cord-enriched splicing signature revealed unexpected mechanistic characteristics that separated it from classic TDP43-mediated repression. Analysis of donor whole-genome sequencing identified three amyotrophic lateral sclerosis cases carrying pathogenic mutations in SOD1, a genetic subset that lacks typical TDP43 aggregation. Remarkably, these SOD1 mutation carriers exhibited elevated inclusion of spinal cryptic splices, such as the alternative start exon in CHCHD6, matching levels detected in sporadic disease cases. Furthermore, cross-referencing spinal cord RNA profiles with established molecular subtypes revealed that all seven spinal cryptic splices were significantly elevated in the neuroinflammatory glial subtype of amyotrophic lateral sclerosis compared to controls, with five showing significant elevation relative to the oxidative stress subtype, indicating an association with regional neuroinflammation.

The investigators sought to determine whether context-specific cryptic splicing arose from differential host gene transcription across anatomical regions or through alternative trans-regulatory RNA-binding proteins. Comparing baseline expression levels of cryptic host genes in control tissues against genome-wide distributions showed that host gene expression provided only a partial explanation. Among one hundred thirty-six host genes analyzed, twenty-five exhibited control expression differences surpassing the ninety-fifth percentile of genome-wide fold changes, and eighteen belonged to the Cortical1 and Cortical2 modules. Profiling five hundred seventy cross-linking immunoprecipitation sequencing datasets covering two hundred fifty-nine RNA-binding proteins revealed that ninety-eight of the one hundred forty-two cryptic splices contained canonical TDP43 binding peaks or guanosine-thymidine motifs within five hundred base pairs of splice sites. Although CSTF2T exhibited binding enrichment adjacent to several spinal splices, its expression was uniform across regions, making it an improbable regulator of spinal splicing diversity.

Because cryptic splicing has historically been linked to reductions in target gene expression, researchers evaluated quantitative correlations between cryptic variant frequency and log-normalized host gene expression across transcriptomic contexts. Across one thousand two hundred forty-six tested associations, the vast majority of correlations were statistically non-significant, demonstrating that cryptic exon inclusion does not universally prompt transcript degradation. Among the two hundred thirty associations that achieved significance at a five percent false discovery rate, two hundred twenty-four exhibited negative correlations, confirming that significant effects almost invariably reduce mature transcript abundance. However, bioinformatic modeling revealed that cryptic splices predicted to introduce premature termination codons and trigger nonsense-mediated decay did not show higher rates of negative expression correlation than non-triggering variants. While STMN2 showed consistent negative correlation with host expression across contexts, other targets such as KALRN exhibited preserved overall expression. These findings indicate that downstream consequences on transcript abundance vary across individual cryptic junctions.

To validate bioinformatic predictions through independent experimental methods, the team engineered reverse transcription quantitative polymerase chain reaction assays targeting sixty-seven cryptic splice variants across lumbar spinal cord and motor cortex specimens from an independent post-mortem cohort. Neighboring tissue sections were analyzed by a neuropathologist blinded to donor diagnoses using immunohistochemistry directed against phosphorylated TDP43 at serine residues 409 and 410. Statistical testing confirmed that twenty-six cryptic splices were significantly elevated in disease tissues at a five percent false discovery rate. Fourteen validated variants exhibited simultaneous elevation in both lumbar spinal cord and motor cortex, seven were elevated exclusively within spinal cord tissue, and five Cortical1 splices demonstrated motor cortex-restricted elevation. Furthermore, quantitative correlation analyses revealed that cryptic splice expression levels aligned closely with neuropathological scores of phosphorylated TDP43 burden. Parallel RNA sequencing on spinal validation samples independently confirmed significant upregulation of STMN2 and CHCHD6 cryptic splices, matching immunohistochemical scores and PCR measurements.

High-resolution spatial localization with BaseScope in situ hybridization confirmed that STMN2 cryptic transcripts were strictly confined to anterior horn motor neurons harboring cytoplasmic phosphorylated TDP43 inclusions, whereas KALRN was undetectable in spinal cord and CHCHD6 exhibited diffuse non-neuronal distribution. In parallel, single-nucleus RNA sequencing across motor and frontal cortex demonstrated that cryptic exon inclusion for ARHGAP32, STMN2, and HS6ST3 was disease-elevated and predominantly localized to layers 2/3, 5, and 6 intratelencephalic excitatory projection neurons. Together with the identification of shared cryptic splices in genes including ADCY3, KCNQ2, and HDGFL2, this comprehensive catalog resolves distinct regional and cell-type splicing architectures, establishing an essential foundation for developing tissue-specific biofluid biomarkers and evaluating targeted therapeutics for neurodegenerative proteinopathies.

Subject of Research: Context-specific cryptic splicing signatures in amyotrophic lateral sclerosis and frontotemporal lobar degeneration

Article Title: Divergent TDP43-regulated and TDP43-independent cryptic splicing in the cortex and spinal cord

Article References: Newton, D. F., Yang, R., Gutierrez, J., Hofmann, J. W., Chalasani, S., Yeh, F. L., Biever, A., & Friedman, B. A. (2026). Divergent TDP43-regulated and TDP43-independent cryptic splicing in the cortex and spinal cord. Molecular Neurodegeneration Advances, 2(1), Article 6. https://doi.org/10.1186/s44477-025-00013-w

Image Credits: AI Generated

DOI: 10.1186/s44477-025-00013-w

Keywords: cryptic splicing, TDP43, amyotrophic lateral sclerosis, frontotemporal lobar degeneration, spinal cord, motor cortex, STMN2, UNC13A, CHCHD6, HS6ST3, excitatory neurons, SOD1, single-nucleus RNA sequencing, RT-qPCR, BaseScope, nonsense-mediated decay, RNA-binding proteins

News Source: Cassandra Pierce. (November 21, 2026). Transcriptomic Meta-Analysis Reveals Divergent Cryptic Splicing in Cortex and Spinal Cord. Scienmag.

Tags: amyotrophic lateral sclerosisBaseScopeCHCHD6cryptic splicingexcitatory neuronsfrontotemporal lobar degenerationHS6ST3motor cortexnonsense-mediated decayRNA-binding proteinsRT-qPCRSingle-nucleus RNA sequencingSOD1spinal cordSTMN2TDP43UNC13A
Share12Tweet7Share2ShareShareShare1

Related Posts

West African Study Finds No Detectable Link Between Carbon Intensity and Mortality

West African Study Finds No Detectable Link Between Carbon Intensity and Mortality

November 22, 2026
Malawi Simulation Shows Health System Strengthening Outperforms Disease-Specific Healthcare Funding

Malawi Simulation Shows Health System Strengthening Outperforms Disease-Specific Healthcare Funding

November 22, 2026

Leadership Support and Adapted Workflows Shape Rural Wisconsin Police Deflection Programs

November 22, 2026

Cadonilimab Plus Lenvatinib Shows Promising Antitumor Activity in Advanced Endometrial Cancer

November 22, 2026

POPULAR NEWS

  • Cadonilimab Plus Lenvatinib Shows Promising Antitumor Activity in Advanced Endometrial Cancer

    Cadonilimab Plus Lenvatinib Shows Promising Antitumor Activity in Advanced Endometrial Cancer

    29 shares
    Share 12 Tweet 7
  • Depression and Parkinson’s Associated With Greatest Quality of Life Reductions in Finland

    29 shares
    Share 12 Tweet 7
  • Ugandan Parasite Surveillance Shows Complex Expansion of Pyrimethamine Resistance Mutation

    29 shares
    Share 12 Tweet 7
  • Dual Immunotherapy Before Surgery Boosts T Cells in Recurrent Glioblastoma

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

West African Study Finds No Detectable Link Between Carbon Intensity and Mortality

GEN1 Resolvase Protects Genome Integrity and Self-Renewal in Mouse Embryonic Stem Cells

Malawi Simulation Shows Health System Strengthening Outperforms Disease-Specific Healthcare Funding

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 89 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.